Roger J. Waltzman's most recent trade in Indaptus Therapeutics Inc was a trade of 75,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Oct. 9, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Indaptus Therapeutics Inc | Roger J. Waltzman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Indaptus Therapeutics Inc | Roger J. Waltzman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Molecular Templates Inc | Roger J. Waltzman | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 170,000 | 170,000 | - | - | Stock Option (right to buy) | |
| Molecular Templates Inc | Roger J. Waltzman | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Molecular Templates Inc | Roger J. Waltzman | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2021 | 125,000 | 125,000 | - | - | Stock Option (right to buy) |